1-3 of 3
Marc Maliepaard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase I Clinical and Pharmacologic Study of Weekly versus Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer

Free
Mirjam Crul, Nadja E. Schoemaker, Dick Pluim, Marc Maliepaard, René W. M. Underberg, Margaret Schot, Rolf W. Sparidans, Paul Baas, Jos H. Beijnen, Nico van Zandwijk, Jan H. M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3526–3533.
Published: 23 September 2003
View articletitled, Randomized Phase I Clinical and Pharmacologic Study of Weekly versus Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for Randomized Phase I Clinical and Pharmacologic Study of Weekly versus Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer in another window
Journal Articles

Expression of the Breast Cancer Resistance Protein in Breast Cancer

Free
Ian F. Faneyte, Petra M. P. Kristel, Marc Maliepaard, George L. Scheffer, Rik J. Scheper, Jan H. M. Schellens, Marc J. van de Vijver
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1068–1074.
Published: 01 April 2002
View articletitled, Expression of the Breast Cancer Resistance Protein in Breast Cancer
Open the PDF for Expression of the Breast Cancer Resistance Protein in Breast Cancer in another window
Journal Articles

Circumvention of Breast Cancer Resistance Protein (BCRP)-mediated Resistance to Camptothecins in Vitro Using Non-Substrate Drugs or the BCRP Inhibitor GF120918

Free
Marc Maliepaard, Margôt A. van Gastelen, Akiko Tohgo, Frederick H. Hausheer, Robert C. A. M. van Waardenburg, Laurina A. de Jong, Dick Pluim, Jos H. Beijnen, Jan H. M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 935–941.
Published: 01 April 2001
View articletitled, Circumvention of Breast Cancer Resistance Protein (BCRP)-mediated Resistance to Camptothecins in Vitro Using Non-Substrate Drugs or the BCRP Inhibitor GF120918
Open the PDF for Circumvention of Breast Cancer Resistance Protein (BCRP)-mediated Resistance to Camptothecins in Vitro Using Non-Substrate Drugs or the BCRP Inhibitor GF120918 in another window